Tag: <span>m&a</span>

From the Editor-in-Chief: The Best ROI — Employee Training and Career Development

I bet you are expecting me to rant and rave about M&A-focused business plans and how they are to blame for just about everything that is wrong with the biotech industry. Well, I guess I will a little, but I’m going to take a slightly different approach this time or you’ll probably quit reading my opinion pieces. So why not step back and look at this financial board game a little differently, where you consider employees to be a far better long-term investment than any company or technology you can buy?

Read MoreFrom the Editor-in-Chief: The Best ROI — Employee Training and Career Development

Biologics Production

biologics biopharmaceuticals employee career development employee training m&a mergers and acquisitions return on investment roi staff training

From the Editor-in-Chief: Building Businesses and Developing Strategic Partnerships

Biologics Production

biologics biopharmaceuticals building businesses entrepreneurship innovation m&a mergers and acquisitions r&d research and development small organizations strategic partnerships

From the Editor-in-Chief: Innovative Small Companies

While I could be deluding myself with wishful thinking, I may be seeing the “new normal” evolving for the biotech industry. The “new normal” may very well be that the mass closing of R&D facilities and the cancellation of major programs is freeing up the CSOs and other entrepreneurs who will start their own companies…

Read MoreFrom the Editor-in-Chief: Innovative Small Companies

Biologics Production

biologics biopharmaceuticals entrepreneurship innovation m&a mergers and acquisitions r&d research and development small organizations